Lupin Limited has informed the Exchange regarding a press release dated November 24, 2015, title”Lupin Receives FDA Approvals for Generic Loestrin Fe 1/20 and Loestrin 1.5/30 Tablets”…….
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
